The present disclosure relates to support structures and, more particularly, to annular support structures, gaskets and the like for use in conjunction with stapling devices, for reducing occurrences of leaking, bleeding and/or stricture.
Staples have traditionally been used to replace suturing when joining or anastomosing various body structures, such as, for example, the bowel or bronchus. The surgical stapling devices employed to apply these staples are generally designed to simultaneously cut and seal an extended segment of tissue in a patient, thus vastly reducing the time and risks of such procedures.
Linear or annular surgical stapling devices are employed by surgeons to sequentially or simultaneously apply one or more linear rows of surgical fasteners, e.g., staples or two-part fasteners, to body tissue for the purpose of joining segments of body tissue together and/or for the creation of anastomoses. Linear surgical stapling devices generally include a pair of jaws or finger-like structures between which body tissue to be joined is placed. When the surgical stapling device is actuated and/or “fired”, firing bars move longitudinally and contact staple drive members in one of the jaws, and surgical staples are pushed through the body tissue and into/against an anvil in the opposite jaw thereby crimping the staples closed. A knife blade may be provided to cut between the rows/lines of staples. Examples of such surgical stapling devices are described in U.S. Pat. Nos. 4,354,628, 5,014,899 and 5,040,715, the entirety of each of which is incorporated herein by reference.
Annular surgical stapling devices generally include an annular staple cartridge assembly including a plurality of annular rows of staples, typically two, an anvil assembly operatively associated with the annular cartridge assembly, and an annular blade disposed internal of the rows of staples. Examples of such annular surgical stapling devices are described in U.S. Pat. Nos. 5,799,857 and 5,915,616 to Robertson et al., the entirety of each of which is incorporated herein by reference.
For most procedures, the use of bare staples, with the staples in direct contact with the patient's tissue, is generally acceptable. The integrity of the tissue will normally serve to prevent the staples from tearing out of the tissue and compromising the sealing before healing has occurred. However, in some surgical operations, surgical supports, e.g., meshes, are employed by surgeons to bridge, repair and/or reinforce tissue defects with a patient, especially those occurring in the abdominal wall, chest wall, diaphragm and other musculo-aponeurotic areas of the body. Examples of surgical supports are disclosed in U.S. Pat. Nos. 3,054,406, 3,124,136, 4,347,847, 4,655,221, 4,838,884 and 5,002,551, the entirety of each of which is incorporated herein by reference.
When the staples are applied in surgical procedures utilizing surgical supports (i.e., reinforcing material), the legs of the staple typically pass from the cartridge jaw through a layer of the surgical support, and through the patient's tissue before encountering the anvil jaw. In an alternative procedure, the legs of the staple typically pass from the cartridge jaw through a first layer of the surgical support, then through the patient's tissue, and finally through a second layer of the surgical support before encountering the anvil jaw. With the staples in place, the stapled tissue is clamped between the layers of the surgical support.
While the surgical supports described above are used in conjunction with linear surgical stapling devices, the need exists for annular support structure for use in conjunction with annular or circular surgical stapling devices, for example, an end-to-end anastomosis stapler such as a Model “EEA™” instrument available from United States Surgical, a Division of Tyco Health-Care Group, LP, Norwalk, Conn. and disclosed in U.S. Pat. No. 5,392,979 to Green et al. In general, an end-to-end anastomosis stapler typically places an array of staples into the approximated sections of a patient's bowels or other tubular organs. The resulting anastomosis contains an inverted section of bowel which contains numerous “B” shaped staples to maintain a secure connection between the approximated sections of bowel.
In addition to the use of surgical staples, biological tissue adhesives have been developed for tissue repair and the creation of anastomoses. Generally, biological adhesives bond separated tissues together to aid in the healing process and to enhance the tissue strength. Such adhesives may be used instead of suturing and stapling, for example, in surgical procedures, for the repair of tissue or the creation of anastomoses.
In addition to the use of biological adhesives, following the formation of the anastomosis, a separate instrument or device is used to apply biological sealants to the outer surface of the anastomosis. Typically, in a separate step, the biological sealants are applied to the outer surface of the anastomosis by spraying on, brushing on, swabbing on, any combinations thereof, or any other method contemplated by those skilled in the art. The biological sealants act to reduce and/or stop the incidents of leakage from the anastomosis.
One possible side effect of any end-to-end bowel anastomosis is its tendency to stenos over time, which stenosis can decrease the diameter of the lumen over time. Accordingly, the need exists for a surgical support structure which operates in conjunction with any end-to-end anastomosis device and assists in maintaining the lumen of the anastomosed bowel or other tubular organ open over time.
The application of suitable biocompatible adhesive offers many advantages to the patient and the surgeon alike, such as, for example, the possible reduction in the number of staples used, immediate sealing of the tissue being treated, a strengthening of the anastomosis, and a reduction in the occurrence of bleeding from the blood vessels, leakage through the tissue joint, and stricture. Moreover, use of biocompatible adhesives tends to minimize foreign body reaction and scarring.
Accordingly, the need exists for an annular support structure which operates in conjunction with any end-to-end, annular or circular stapling device and assists in maintaining the lumen of the anastomosed bowel or other tubular organ patent or open over time.
A need also exists for an annular support structure which operates in conjunction with any end-to-end, annular or circular stapling device to reduce the trauma suffered by the patient, reduce the instances of leakage, reduce the instances of bleeding, and create a relatively strong bond between adjacent body tissues.
A need also exists for an annular support structure configured to provide support to the anastomosed tissue, preferably, distally and/or proximally of the staple line.
According to an aspect of the present disclosure, an apparatus for forming an anastomosis between adjacent intestinal sections of tissue is provided. The apparatus includes an anastomosis device having an anvil and a tubular body portion, wherein the anvil is selectively attachable to the tubular body portion by a shaft; and a support structure for deposition between the intestinal sections of tissue. The support structure includes a body defining an aperture therein for receiving the shaft. The body has an outer terminal edge. The support structure includes at least one layer of expandable material disposed at the outer terminal edge of the body.
The at least one layer of expandable material may include a first and a second membrane extending radially outward from the outer terminal edge of the body.
The aperture may be defined by an inner terminal edge of the body. The inner terminal edge may be disposed radially inward of staple receiving slots of a staple cartridge assembly disposed in the tubular body.
It is envisioned that each of the first and second membranes is made from a polymeric film, such as, for example, polyethylene. The support structure has an undeployed condition wherein the first and second membranes are rolled-up towards the body, and a deployed condition wherein the first membrane extends in a substantially distal direction from the body and the second membrane extends in a substantially proximal direction from the body.
The apparatus may further include a rip-cord for expanding the first and second membranes. The rip-cord is rolled-up into each of the first and second membranes when the support structure is in the undeployed condition.
Each membrane may include a first inner layer and a second outer layer. The second outer layer of each membrane may swell at a rate greater than the first inner layer. The second outer layers of the first and second membranes are made from a hydrogel. The first inner layer of each of the first and second membranes may be constructed from a substantially non-absorbable material. The first inner layer of each of the first and second membranes may be fabricated from a bio-absorbable mesh fabric.
According to another aspect of the present disclosure, a method of disposing a support structure between adjacent intestinal sections is provided. The method includes the step of providing a circular surgical anastomosis device. The circular surgical anastomosis device includes an anvil assembly having an anvil member and a first shaft; and a tubular body portion having an annular knife operatively disposed therein and a second shaft disposed radially inward of the annular knife, the first shaft of the anvil assembly being selectively attachable to the second shaft of the tubular body.
The method further includes the steps of inserting the anvil assembly into a first intestinal section; inserting the tubular body portion into a second intestinal section; disposing a support structure between the first intestinal section and the second intestinal section, the support structure having at least one layer of expandable material; approximating the anvil assembly and tubular body portion with one another so that an end portion of the first intestinal section, the support structure, and an end portion of the second intestinal section are disposed between the anvil member and the tubular body portion, the support structure being disposed between the first intestinal section and the second intestinal section; firing the surgical anastomosis device to sever the portions of the first and second intestinal sections disposed radially inward of the annular knife, and to touch the portions of the first and second intestinal sections radially outward of the annular knife against the structure; and expanding the at least one layer of expandable material.
The anvil assembly may include a first shaft and the tubular body portion includes a second shaft disposed radially inward of the annular knife. Desirably, the first shaft of the anvil member is attachable to the second shaft of the tubular body portion. Accordingly, the method may further include the step of attaching the first shaft of the anvil assembly to the second shaft of the tubular body portion prior to the step of approximating the anvil assembly to the tubular body portion.
The support structure may include an aperture formed therein. Accordingly, the method may further include the step of inserting one of the first shaft of the anvil assembly and the second shaft of the tubular body portion into the aperture of the support structure prior to the step of attaching the first shaft of the anvil assembly to the second shaft of the tubular body portion.
The tubular body portion may carry a plurality of surgical staples. The surgical staples may be disposed radially outward of the annular knife. Accordingly, in use, firing the surgical anastomosis device includes deploying the plurality of staples so that the staples penetrate a first interstitial section, the support structure and then a second interstitial section.
The support structure may include a body and a first and a second membrane extending radially outward from the body. Each of the first and second membranes of the support structure may be made from a polymeric film, such as, for example, polyethylene.
In use, expanding the at least one layer of expandable material may include deploying the first and second membranes from a rolled-up condition to an expanded condition. In the expanded condition, the first membrane may extend in a substantially distal direction from the body portion of the support structure and the second membrane may extend in a substantially proximal direction from the body portion of the support structure.
The method may further include the step of pulling on at least one rip-cord to expand the first and second membranes.
Each membrane of the support structure may include a first inner layer and a second outer layer. Accordingly, expanding the at least one layer may include expanding the second outer layer at a greater rate than the first inner layer. The second outer layer of each membrane of the support structure may swell at a rate greater than the first inner layer.
The second outer layers of the first and second membranes may be made from a hydrogel. The first inner layer of each of the first and second membranes of the support structure may be constructed from a substantially non-absorbable material. The first inner layer of each of the first and second membranes may be fabricated from a bio-absorbable mesh fabric. The body may be perforated or porous.
The at least one layer of expandable material may expand upon fluid absorption.
The body may be fabricated from at least one of a polyglactic material, a glycolide homopolymer, and a synthetic absorbable lactomer 9-1 material. The body may be a mesh or other fabric.
The body may include a wound treatment material. The wound treatment material is desirably at least one of an adhesive, a sealant, a hemostat, and a medicament.
The body may be compressible so that the outer terminal edge of the body extends beyond the outer radial surface of the anvil and tubular body portion. Accordingly, the body may be fabricated from foam. The body has a first thickness greater than one quarter of a diameter of the body.
The support structure has an unhydrated condition wherein the body has a first diameter and a first thickness, and a hydrated condition wherein the body has a second diameter greater than the first diameter and a second thickness greater than the first thickness. The body desirably expands from the first diameter and the first thickness to a second diameter and a second thickness upon application of a fluid thereto.
The body may be constructed from a first part of a two-part wound treatment material, and the fluid applied thereto is a second part of the two-part wound treatment material.
According to yet another aspect of the present disclosure, a method of performing a surgical anastomosis procedure is provided. The method includes the steps of providing an anastomosis apparatus having an anvil assembly movably mounted with respect to a tubular body portion; providing a support structure including a body having an outer terminal edge, and an aperture therethrough, the body being compressible; disposing an anvil assembly into a first intestinal section; disposing a distal end portion of the surgical stapling apparatus in a second intestinal section; positioning the support structure on a shaft of the anvil assembly; approximating the anvil assembly and the tubular body portion to capture the body of the support structure between the first intestinal section and the second intestinal section and to compress the body portion therebetween so that the body extends radially beyond the anvil member and the tubular body portion to seal the perimeter of the anastomosis site; and firing the anastomosis apparatus to join the first intestinal section, support structure, and second intestinal section.
The support structure may have an unhydrated condition wherein the body has a first diameter and a first thickness, and a hydrated condition wherein the body has a second diameter greater than the first diameter and a second thickness greater than the first thickness. The support structure may be pre-mounted onto the shaft of the anvil assembly prior to positioning of the anvil assembly in the first intestinal section. Accordingly, prior to approximating the anvil assembly and the tubular body portion, the method further includes the step of hydrating the support structure to expand the body from the first diameter and the first thickness to a second diameter and a second thickness.
The body may be constructed from a first part of a two-part wound treatment material, and the fluid applied thereto is a second part of the two-part wound treatment material.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the disclosure and, together with a general description of the disclosure given above and the detailed description of the embodiments given below, serve to explain the principles of the disclosure, wherein:
Embodiments of the presently disclosed annular adhesive structures will now be described in detail with reference to the drawing figures wherein like reference numerals identify similar or identical elements. As used herein and as is traditional, the term “distal” refers to that portion which is furthest from the user while the term “proximal” refers to that portion which is closest to the user.
Referring initially to
Staple cartridge assembly 22 may be fixedly connected to the distal end of tubular body portion 20 or may be configured to concentrically fit within the distal end of tubular body portion 20. Typically, staple cartridge assembly 22 includes a staple pusher (not shown) including a proximal portion having a generally frusto-conical shape and a distal portion defining two concentric rings of peripherally spaced fingers (not shown), each one of which is received within a respective staple receiving slot 36.
Typically, a knife (not shown), substantially in the form of an open cup with the rim thereof defining a knife edge, is disposed within staple cartridge assembly 22 and mounted to a distal surface of a staple pusher (not shown). The knife edge is disposed radially inward of the pair of annular arrays of staples. Accordingly, in use, as the staple pusher is advanced, the knife is also advanced axially outward.
Reference may be made to U.S. Pat. No. 5,915,616 to Viola et al., the entire content of which is incorporated herein by reference, for a detailed discussion of annular stapling device 10.
Turning now to
In one embodiment, structure 100 is sized such that when structure 100 is operatively associated with stapling device 10, as will be described in greater detail below, outer terminal edge 106 extends radially beyond staple retaining pockets 36 of staple cartridge assembly 22. Additionally, aperture 104 of structure 100 is sized to at least receive shaft 28 of anvil assembly 30 therethrough. In another embodiment, the distance between outer terminal edge 106 and inner terminal edge 108 is substantially equal to a width of a tissue contact surface 24 (see
It is contemplated that body 102 of structure 100 may be fabricated from or include a surgical grade, biocompatible, non-absorbable (i.e., permanent) mesh or material desirably impregnated with an adhesive, sealant and/or other medicament. For example, body 102 may be fabricated from “TEFLON”, which is a registered trademark owned by DuPont de Nemours & Co. It is further contemplated that body 102 may be fabricated from a biocompatible polymeric foam, felt, polytetrafluoroethylene (ePTFE), gelatin, fabric or the like, or any other biocompatible material.
Non-absorbable materials used for body 102 include, and are not limited to, those that are fabricated from such polymers as polyethylene, polypropylene, nylon, polyethylene terephthalate, polytetrafluoroethylene, polyvinylidene fluoride, and the like. Further non-absorbable materials include and are not limited to stainless steel, titanium and the like.
In one embodiment, body 102 of structure 100 may be fabricated from a bio-absorbable material which is desirably impregnated with an adhesive, sealant, and/or other medicament (i.e., wound treatment material). Accordingly, in use, the sealant component of structure 100 functions to retard any bleeding which may occur from the tissue, the adhesive component of structure 100 functions to secure the approximated tissue together, and the bio-absorbability of structure 100 allows for the at least a portion of structure 100 to be absorbed into the body after a predetermined amount of time. For example, structure 100 may remain in place in the body for approximately 2-3 weeks in order for the anastomosis to sufficiently heal prior to structure 100 being absorbed into the body.
Bio-absorbable materials used for body 102 of structure 100 include, and are not limited to, those fabricated from homopolymers, copolymers or blends obtained from one or more monomers selected from the group consisting of glycolide, glycolic acid, lactide, lactic acid, p-dioxanone, α-caprolactone and trimethylene carbonate. Other bio-absorbable materials include and are not limited to, for example, Polyglycolic Acid (PGA) and Polylactic Acid (PLA). In one embodiment, body 102 may be fabricated from bio-absorbable felt, ePTFE, gelatin or any other bio-absorbable materials. Illustrative examples of bioabsorbable materials include DEXON™ mesh, absorbable felts, such as POLYSORB™, and foams, such as polyurethane.
It is envisioned that body 102 of structure 100 may be impregnated with a wound treatment material “W” which is a pre-cured adhesive or sealant. The pre-cured sealant or adhesive will react with the moisture and/or heat of the body tissue to thereby activate the sealing and/or adhesive properties of the sealant or adhesive. It is envisioned that the pre-cured sealant or adhesive may be a hydro-gel or the like.
It is contemplated that the wound treatment material “W” is any material for joining, healing, sealing or otherwise treating tissue. In a preferred embodiment, the wound treatment material is a bio-compatible sealant, including, and not limited, to sealants which cure upon tissue contact, sealants which cure upon exposure to ultraviolet (UV) light, sealants which are two-part systems which are kept isolated from one another and are combined or any combinations thereof. Any known suitable adhesive may be used. In one embodiment, it is contemplated that such sealants and/or adhesives are curable. For example, sealants may have a cure time of from about 10 to 15 seconds may be used. In preferred embodiments, the sealant and/or adhesive is a bioabsorbable and/or bio-resorbable material. In another embodiment, it is contemplated that a sealant and/or adhesive having a cure time of about 30 seconds may be used. It is further envisioned that wound treatment material “W” may be a pre-cured adhesive or sealant.
In certain preferred embodiments, the wound treatment material comprises a sealant. Such a sealant is desirably a PEG-based material. Examples of classes of materials useful as the sealant and/or adhesive include acrylate or methacrylate functional hydrogels in the presence of a biocompatible photoinitiator, alkyl-cyanoacrylates, isocyanate functional macromers with or without amine functional macromers, succinimidyl ester functional macromers with amine or sulfhydryl functional macromers, epoxy functional macromers with amine functional macromers, mixtures of proteins or polypeptides in the presence of aldehyde crosslinkers, Genipin, or water-soluble carbodiimides, anionic polysaccharides in the presence of polyvalent cations, etc.
Some specific materials which may be utilized include isocyanate terminated hydrophilic urethane prepolymers derived from organic polyisocyanates and oxyethylene-based diols or polyols, including those disclosed in U.S. Pat. Nos. 6,702,731 and 6,296,607 and U.S. Published Patent Application No. 2004/0068078; alpha-cyanoacrylate based adhesives including those disclosed in U.S. Pat. No. 6,565,840; alkyl ester based cyanoacrylate adhesives including those disclosed in U.S. Pat. No. 6,620,846; adhesives based on biocompatible cross-linked polymers formed from water soluble precursors having electrophilic and nucleophilic groups capable of reacting and cross-linking in situ, including those disclosed in U.S. Pat. No. 6,566,406; two part adhesive systems including those based upon polyalkylene oxide backbones substituted with one or more isocyanate groups in combination with bioabsorbable diamine compounds, or polyalkylene oxide backbones substituted with one or more amine groups in combination with bioabsorbable diisoycanate compounds as disclosed in U.S. Published Patent Application No. 2003/0032734, the contents of which are incorporated by reference herein; and isocyanate terminated hydrophilic urethane prepolymers derived from aromatic diisocyanates and polyols as disclosed in U.S. Published Patent Application No. 2004/0115229, the contents of which are incorporated by reference herein.
It is envisioned and within the scope of the present disclosure that wound treatment material “W” may include one or a combination of adhesives, hemostats, sealants, or any other tissue or wound-treating material. Surgical biocompatible wound treatment materials “W”, which may be used in accordance with the present disclosure, include adhesives whose function is to attach or hold organs, tissues or structures, sealants to prevent fluid leakage, and hemostats to halt or prevent bleeding. Examples of adhesives which can be employed include protein derived, aldehyde-based adhesive materials, for example, the commercially available albumin/glutaraldehyde materials sold under the trade designation BioGlue™ by Cryolife, Inc., and cyanoacrylate-based materials sold under the trade designations Indermil™ and Derma Bond™ by Tyco Healthcare Group, LP and Ethicon Endosurgery, Inc., respectively. Examples of sealants, which can be employed, include fibrin sealants and collagen-based and synthetic polymer-based tissue sealants. Examples of commercially available sealants are synthetic polyethylene glycol-based, hydrogel materials sold under the trade designation CoSeal™ by Cohesion Technologies and Baxter International, Inc. Examples of hemostat materials, which can be employed, include fibrin-based, collagen-based, oxidized regenerated cellulose-based and gelatin-based topical hemostats. Examples of commercially available hemostat materials are fibrinogen-thrombin combination materials sold under the trade designations CoStasis™ by Tyco Healthcare Group, LP, and Tisseel™ sold by Baxter International, Inc. Hemostats herein include astringents, e.g., aluminum sulfate, and coagulants.
The medicament may include one or more medically and/or surgically useful substances such as drugs, enzymes, growth factors, peptides, proteins, dyes, diagnostic agents or hemostasis agents, monoclonal antibodies, or any other pharmaceutical used in the prevention of stenosis. The medicament may be disposed on structure 100 or impregnated into structure 100. The medicament may include one or more medically and/or surgically useful substances such as drugs, enzymes, growth factors, peptides, proteins, dyes, diagnostic agents or hemostasis agents, monoclonal antibodies, or any other pharmaceutical used in the prevention of stenosis.
Wound treatment material “W” may include visco-elastic film forming materials, cross-linking reactive agents, and energy curable adhesives. It is envisioned that wound treatment material “W”, and in particular, adhesive may be cured with the application of water and/or glycerin thereto. In this manner, the water and/or glycerin cure the adhesive and hydrate the wound.
It is further contemplated that wound treatment material “W” may include, for example, compositions and/or compounds which accelerate or beneficially modify the healing process when particles of the composition and/or compound are applied to or exposed to a surgical repair site. For example, the wound treatment material “W” may be a therapeutic agent which will be deposited at the repair site. The therapeutic agent can be chosen for its antimicrobial properties, capability for promoting repair or reconstruction and/or new tissue growth. Antimicrobial agents such as broad spectrum antibiotic (gentamycin sulfate, erythromycin or derivatized glycopeptides) which are slowly released into the tissue can be applied in this manner to aid in combating clinical and sub-clinical infections in a tissue repair site. To promote repair and/or tissue growth, wound treatment material “W” may include one or several growth promoting factors, e.g., fibroblast growth factor, bone growth factor, epidermal growth factor, platelet derived growth factor, macrophage derived growth factor, alveolar derived growth factor, monocyte derived growth factor, magainin, and so forth. Some therapeutic indications are: glycerol with tissue or kidney plasminogen activator to cause thrombosis, superoxide dimutase to scavenge tissue damaging free radicals, tumor necrosis factor for cancer therapy or colony stimulating factor and interferon, interleukin-2 or other lymphokine to enhance the immune system.
In one embodiment, it is contemplated that body 102 of structure 100 may be impregnated with a first component of a two-part adhesive and that the staples, retained in staple receiving slots 36 of staple cartridge assembly 22, may be coated with a second component (e.g., a reactant) of the two-part adhesive. In this manner, the first component of the adhesive is activated when the staples penetrate and capture body 102 of structure 100 during the firing sequence of surgical stapling device 10, and the two components of the adhesive contact one another.
As seen in
As seen in
As seen in
In one embodiment, it is envisioned that body 102 of support structure 100 is formed of a foam material overmolded onto a relatively thin flexible material or film making up membranes or sleeves 140, 142. Desirably, when un-rolled or un-furled, each membrane 140, 142 extends approximately 2.0 cm from body 102. In other words, when un-rolled or un-furled, first membrane 140 extends from body 102 by approximately 2.0 cm from upper surface 110 of body 102, and second membrane 142 extends from body 102 approximately 2.0 cm from lower surface 112 of body 102.
Turning now to
Annular support structure 100 is then placed onto shaft 28 of anvil assembly 30 prior to the coupling of anvil assembly 30 to the distal end of tubular body portion 20. In particular, shaft 28 of anvil assembly 30 is inserted into aperture 104 of body portion 102. Following positioning of structure 100 onto shaft 28 of anvil assembly 30, the surgeon maneuvers anvil assembly 30 until the proximal end of shaft 28 is inserted into the distal end of tubular body portion 20 of surgical stapling device 10, wherein the mounting structure (not shown) within the distal end of tubular body portion 20 engages shaft 28 to effect the mounting.
Thereafter, as seen in
Membranes 140, 142 extend a predetermined distance over intestinal sections 66 and 68 (e.g., approximately 2 cm). When un-rolled or un-furled, membranes 140, 142 will adhere to the surface of intestinal sections 66, 68. Membranes 140 and 142 function to inhibit leakage from the anastomosis site and/or function to strengthen or reinforce intestinal sections 66, 68. With membranes 140, 142 deployed, as seen in
Turning now to
In accordance with one embodiment, it is envisioned that inner layer 150a, 152a of membranes 150, 152 are constructed from a substantially non-absorbable (i.e., does not absorb moisture therein) or non-expanding (i.e., static) material, such as, for example, a bio-absorbable mesh fabricated from polyglycolic acid, sold under the tradename DEXON™, available from Tyco Healthcare Group LP, Norwalk, Conn. It is also envisioned that outer layer 150b, 152b of membranes 150, 152 are constructed from an absorbable or expanding (i.e., dynamic) material, such as, for example, hydrogel and the like.
Desirably, each membrane 150 and 152 includes a hydrogel outer layer 150b, 152b laminated to a bio-absorbable mesh inner layer 150a, 152a. Furthermore, support structure 100 includes a foam body 102 laminated over a pair of dual layered membranes 150, 152. While each membrane 150, 152 desirably includes a pair of layers, it is envisioned and within the scope of the present disclosure for membranes 150, 152 to include any number of layers.
Accordingly, with reference to
Turning now to
With body portion 102 of support structure 100 captured between intestinal sections 66, 68, as seen in
Desirably, membranes 150, 152 extend a predetermined distance over intestinal sections 66 and 68 (e.g., approximately 2 cm). Accordingly, when deployed, membranes 150, 152 will adhere to the surface of intestinal sections 66, 68. Membranes 150, 152 function to inhibit leakage from the anastomosis site and/or function to strengthen or reinforce intestinal sections 66, 68. With membranes 150, 152 deployed, as seen in
As seen in
Ribs 156, 158 are fabricated from a shape memory material, alloy or the like, preferably, NITINOL™ and the like. It is further envisioned that ribs 156, 158 may be fabricated from a bio-absorbable material.
Ribs 156, 158 have a memorized shape which is oriented substantially parallel to the central “X” axis of support structure 100. In this manner, support structure 100 has a first or un-deployed condition in which ribs 156, 158 are in a biased rolled-up condition and membranes 150, 152 are also rolled-up, and a second or deployed condition in which ribs 156, 158 are in their memorized shape or condition and membranes 150, 152 are extended.
In use, with support structure in an un-deployed condition, support structure 100 is positioned in shaft 28 of anvil assembly 30. With support structure 100 so positioned, support structure 100 is deployed when ribs 156, 158 return to their memorized conditions. In particular, the return of ribs 156, 158 to their memorized conditions extends membranes 150, 152 over intestinal sections 66 and 68 and/or in a direction substantially parallel to the central “X” axis.
Turning now to
As seen in
With continued reference to
Turning now to
As seen in
As seen in
As seen in
Turning now to
Turning now to
In addition to reducing leakage from the anastomosis site, due to the compressible nature of body 302 of support 300, the body 302 is capable of filling any voids or recesses which may exist in the surface of intestinal sections 66, 68.
Following the approximation of anvil assembly 30 and tubular body portion 20, to approximate intestinal sections 66, 68 and capture body 302 of support structure 300 therebetween, surgical stapling device 10 is fired thereby stapling intestinal sections 66, 68 to one another and cutting the portion of tissue and support structure 300 disposed radially inward of the knife, to complete the anastomosis.
As seen in
As seen in
In use, with support structure 300 in the un-expanded condition, anvil assembly 30 is introduced into the surgical site as described above. Following connection of anvil assembly 30 to the distal end of tubular body portion 20, fluid “F” is delivered to body 302 of support structure 300, thereby causing support structure 300 to expand. Following expansion of support structure 300, the surgical procedure is continued as described above.
It is envisioned and within the scope of the present disclosure that the fluid “F” may be a cross-linker or other substance which is reactive with the foam of body 302 of support structure 300 to thereby form or create a support structure 300 of wound treatment material (e.g., adhesive, sealant, hemostat, medicament, etc.). It is contemplated that body 302 of support structure 300 may be a foam made from a first part of a two-part wound treatment material, and fluid “F” may include a second part of the two-part wound treatment material. In this manner, the wound treatment material is formed upon interaction of fluid “F” with body 302 of support structure 300.
From the foregoing, it will be appreciated that the support structures of the present disclosure function to strengthen the anastomosis and reduce the occurrence of bleeding, leaking and stricture. It is also to be appreciated that the support structures of the present disclosure may be utilized in a number of other applications and is not limited solely to bowel or bronchus anastomosis.
While several particular forms of the support structures have been illustrated and described, it will also be apparent that various modifications can be made without departing from the spirit and scope of the present disclosure. For example, it is envisioned and within the scope of the present disclosure for an ultraviolet light activated adhesive to be used in connection with any of the support structures described above. In use, either prior to or following firing of surgical stapling device 10, the support structure is irradiated with UV light to thereby activate the adhesive thereof.
It is further contemplated that each of the support structures described herein may be used with an annular surgical anastomosing device, not including any staples for securing tissue together, which is capable of approximating, adhering and cutting tissue.
Thus, it should be understood that various changes in form, detail and application of the support structures of the present disclosure may be made without departing from the spirit and scope of the present disclosure.
The present application is a continuation of U.S. application Ser. No. 15/201,875, filed on Jul. 5, 2016, which is a divisional of U.S. application Ser. No. 13/848,265, filed on Mar. 21, 2013, now U.S. Pat. No. 9,445,817, which is a continuation of U.S. application Ser. No. 13/076,550, filed on Mar. 31, 2011, now U.S. Pat. No. 8,424,742, which is a divisional of U.S. application Ser. No. 11/241,267, filed on Sep. 30, 2005, now U.S. Pat. No. 7,938,307, which claims the benefit of and priority to each of U.S. Provisional Application Ser. No. 60/620,066, filed Oct. 18, 2004, and U.S. Provisional Application Ser. No. 60/620,065, filed Oct. 18, 2004, the entire contents of each of which being incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3054406 | Usher | Sep 1962 | A |
3079606 | Bobrov et al. | Mar 1963 | A |
3124136 | Usher | Mar 1964 | A |
3364200 | Ashton et al. | Jan 1968 | A |
3490675 | Green et al. | Jan 1970 | A |
3499591 | Green | Mar 1970 | A |
3797494 | Zaffaroni | Mar 1974 | A |
3937222 | Banko | Feb 1976 | A |
3939068 | Wendt et al. | Feb 1976 | A |
3948666 | Kitanishi et al. | Apr 1976 | A |
4064062 | Yurko | Dec 1977 | A |
4166800 | Fong | Sep 1979 | A |
4282236 | Broom | Aug 1981 | A |
4347847 | Usher | Sep 1982 | A |
4354628 | Green | Oct 1982 | A |
4416698 | McCorsley, III | Nov 1983 | A |
4429695 | Green | Feb 1984 | A |
4452245 | Usher | Jun 1984 | A |
4603693 | Conta et al. | Aug 1986 | A |
4605730 | Shalaby et al. | Aug 1986 | A |
4626253 | Broadnax, Jr. | Dec 1986 | A |
4655221 | Devereux | Apr 1987 | A |
4665917 | Clanton et al. | May 1987 | A |
4703887 | Clanton et al. | Nov 1987 | A |
4834090 | Moore | May 1989 | A |
4838884 | Dumican et al. | Jun 1989 | A |
4873977 | Avant et al. | Oct 1989 | A |
4927640 | Dahlinder et al. | May 1990 | A |
4930674 | Barak | Jun 1990 | A |
5002551 | Linsky et al. | Mar 1991 | A |
5014899 | Presty et al. | May 1991 | A |
5040715 | Green et al. | Aug 1991 | A |
5057334 | Vail | Oct 1991 | A |
5065929 | Schulze et al. | Nov 1991 | A |
5112496 | Dhawan et al. | May 1992 | A |
5156613 | Sawyer | Oct 1992 | A |
5156614 | Green et al. | Oct 1992 | A |
5162430 | Rhee et al. | Nov 1992 | A |
5205459 | Brinkerhoff et al. | Apr 1993 | A |
5254113 | Wilk | Oct 1993 | A |
5261920 | Main et al. | Nov 1993 | A |
5263629 | Trumbull et al. | Nov 1993 | A |
5281197 | Arias et al. | Jan 1994 | A |
5307976 | Olson et al. | May 1994 | A |
5309927 | Welch | May 1994 | A |
5312023 | Green et al. | May 1994 | A |
5314471 | Brauker et al. | May 1994 | A |
5318221 | Green et al. | Jun 1994 | A |
5318531 | Leone | Jun 1994 | A |
5324775 | Rhee et al. | Jun 1994 | A |
5326013 | Green et al. | Jul 1994 | A |
5332142 | Robinson et al. | Jul 1994 | A |
5344454 | Clarke et al. | Sep 1994 | A |
5346501 | Regula et al. | Sep 1994 | A |
5392979 | Green et al. | Feb 1995 | A |
5397324 | Carroll et al. | Mar 1995 | A |
5405072 | Zlock et al. | Apr 1995 | A |
5410016 | Hubbell et al. | Apr 1995 | A |
5425745 | Green et al. | Jun 1995 | A |
5441193 | Gravener | Aug 1995 | A |
5441507 | Wilk | Aug 1995 | A |
5443198 | Viola et al. | Aug 1995 | A |
5465896 | Allen et al. | Nov 1995 | A |
5468253 | Bezwada et al. | Nov 1995 | A |
5484913 | Stilwell et al. | Jan 1996 | A |
5503638 | Cooper et al. | Apr 1996 | A |
5505952 | Jiang et al. | Apr 1996 | A |
5514379 | Weissleder et al. | May 1996 | A |
5542594 | McKean et al. | Aug 1996 | A |
5543441 | Rhee et al. | Aug 1996 | A |
5549628 | Cooper et al. | Aug 1996 | A |
5550187 | Rhee et al. | Aug 1996 | A |
5554119 | Harrison et al. | Sep 1996 | A |
5575803 | Cooper et al. | Nov 1996 | A |
5588579 | Schnut et al. | Dec 1996 | A |
5611775 | Machold et al. | Mar 1997 | A |
5645915 | Kranzler et al. | Jul 1997 | A |
5653756 | Clarke et al. | Aug 1997 | A |
5669934 | Sawyer | Sep 1997 | A |
5683809 | Freeman et al. | Nov 1997 | A |
5690675 | Sawyer et al. | Nov 1997 | A |
5702409 | Rayburn et al. | Dec 1997 | A |
5735833 | Olson | Apr 1998 | A |
5749895 | Sawyer et al. | May 1998 | A |
5752965 | Francis | May 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5762256 | Mastri et al. | Jun 1998 | A |
5766188 | Igaki | Jun 1998 | A |
5769892 | Kingwell | Jun 1998 | A |
5782396 | Mastri et al. | Jul 1998 | A |
5799857 | Robertson et al. | Sep 1998 | A |
5810855 | Rayburn et al. | Sep 1998 | A |
5814057 | Oi et al. | Sep 1998 | A |
5819350 | Wang | Oct 1998 | A |
5824015 | Sawyer | Oct 1998 | A |
5833695 | Yoon | Nov 1998 | A |
5843033 | Ropiak | Dec 1998 | A |
5843096 | Igaki et al. | Dec 1998 | A |
5866561 | Ungs | Feb 1999 | A |
5871135 | Williamson, IV et al. | Feb 1999 | A |
5874500 | Rhee et al. | Feb 1999 | A |
5895412 | Tucker | Apr 1999 | A |
5895415 | Chow et al. | Apr 1999 | A |
5902312 | Frater et al. | May 1999 | A |
5908427 | McKean et al. | Jun 1999 | A |
5915616 | Viola et al. | Jun 1999 | A |
5931165 | Reich et al. | Aug 1999 | A |
5931847 | Bittner et al. | Aug 1999 | A |
5957363 | Heck | Sep 1999 | A |
5964394 | Robertson | Oct 1999 | A |
5964774 | McKean et al. | Oct 1999 | A |
5997895 | Narotam et al. | Dec 1999 | A |
6019791 | Wood | Feb 2000 | A |
6030392 | Dakov | Feb 2000 | A |
6032849 | Mastri et al. | Mar 2000 | A |
6045560 | McKean et al. | Apr 2000 | A |
6063097 | Oi et al. | May 2000 | A |
6080169 | Turtel | Jun 2000 | A |
6093557 | Pui et al. | Jul 2000 | A |
6099551 | Gabbay | Aug 2000 | A |
6142933 | Longo et al. | Nov 2000 | A |
6149641 | Ungs | Nov 2000 | A |
6149667 | Hovland et al. | Nov 2000 | A |
6152943 | Sawhney | Nov 2000 | A |
6155265 | Hammerslag | Dec 2000 | A |
6156677 | Brown Reed et al. | Dec 2000 | A |
6165201 | Sawhney et al. | Dec 2000 | A |
6179862 | Sawhney | Jan 2001 | B1 |
6210439 | Firmin et al. | Apr 2001 | B1 |
6214020 | Mulhauser et al. | Apr 2001 | B1 |
6228051 | Trumbull | May 2001 | B1 |
6241139 | Milliman et al. | Jun 2001 | B1 |
6258107 | Balazs et al. | Jul 2001 | B1 |
6267772 | Mulhauser et al. | Jul 2001 | B1 |
6270530 | Eldridge et al. | Aug 2001 | B1 |
6273897 | Dalessandro et al. | Aug 2001 | B1 |
6280453 | Kugel et al. | Aug 2001 | B1 |
6287323 | Hammerslag | Sep 2001 | B1 |
6296607 | Milbocker | Oct 2001 | B1 |
6299631 | Shalaby | Oct 2001 | B1 |
6309569 | Farrar et al. | Oct 2001 | B1 |
6312457 | DiMatteo et al. | Nov 2001 | B1 |
6312474 | Francis et al. | Nov 2001 | B1 |
6325810 | Hamilton et al. | Dec 2001 | B1 |
6330965 | Milliman et al. | Dec 2001 | B1 |
6398797 | Bombard et al. | Jun 2002 | B2 |
6399362 | Pui et al. | Jun 2002 | B1 |
6436030 | Rehil | Aug 2002 | B2 |
6451029 | Yeatman | Sep 2002 | B1 |
6454780 | Wallace | Sep 2002 | B1 |
6461368 | Fogarty et al. | Oct 2002 | B2 |
6488197 | Whitman | Dec 2002 | B1 |
6491201 | Whitman | Dec 2002 | B1 |
6494889 | Fleischman et al. | Dec 2002 | B1 |
6500777 | Wiseman et al. | Dec 2002 | B1 |
6503257 | Grant et al. | Jan 2003 | B2 |
6514283 | DiMatteo et al. | Feb 2003 | B2 |
6514534 | Sawhney | Feb 2003 | B1 |
6517566 | Hovland et al. | Feb 2003 | B1 |
6551356 | Rousseau | Apr 2003 | B2 |
6565840 | Clark et al. | May 2003 | B1 |
6566406 | Pathak et al. | May 2003 | B1 |
6566407 | Holmes-Farley et al. | May 2003 | B2 |
6568398 | Cohen | May 2003 | B2 |
6589269 | Zhu et al. | Jul 2003 | B2 |
6590095 | Schleicher et al. | Jul 2003 | B1 |
6592597 | Grant et al. | Jul 2003 | B2 |
6605294 | Sawhney | Aug 2003 | B2 |
6610006 | Amid et al. | Aug 2003 | B1 |
6620846 | Jonn et al. | Sep 2003 | B1 |
6623452 | Chien et al. | Sep 2003 | B2 |
6627749 | Kumar | Sep 2003 | B1 |
6638285 | Gabbay | Oct 2003 | B2 |
6652594 | Francis et al. | Nov 2003 | B2 |
6656193 | Grant et al. | Dec 2003 | B2 |
6656200 | Li et al. | Dec 2003 | B2 |
6669735 | Pelissier | Dec 2003 | B1 |
6673093 | Sawhney | Jan 2004 | B1 |
6677258 | Carroll et al. | Jan 2004 | B2 |
6681979 | Whitman | Jan 2004 | B2 |
6685714 | Rousseau | Feb 2004 | B2 |
6695199 | Whitman | Feb 2004 | B2 |
6702731 | Milbocker | Mar 2004 | B2 |
6702828 | Whayne | Mar 2004 | B2 |
6703047 | Sawhney et al. | Mar 2004 | B2 |
6704210 | Myers | Mar 2004 | B1 |
6723114 | Shalaby | Apr 2004 | B2 |
6726706 | Dominguez | Apr 2004 | B2 |
6736823 | Darois et al. | May 2004 | B2 |
6736854 | Vadurro et al. | May 2004 | B2 |
6746458 | Cloud | Jun 2004 | B1 |
6746869 | Pui et al. | Jun 2004 | B2 |
6764720 | Pui et al. | Jul 2004 | B2 |
6773458 | Brauker et al. | Aug 2004 | B1 |
6818018 | Sawhney | Nov 2004 | B1 |
6835336 | Watt | Dec 2004 | B2 |
6838493 | Williams et al. | Jan 2005 | B2 |
6843252 | Harrison et al. | Jan 2005 | B2 |
6846308 | Whitman et al. | Jan 2005 | B2 |
6867247 | Williams et al. | Mar 2005 | B2 |
6894140 | Roby | May 2005 | B2 |
6896684 | Monassevitch et al. | May 2005 | B2 |
6927315 | Heinecke et al. | Aug 2005 | B1 |
6939358 | Palacios et al. | Sep 2005 | B2 |
6946196 | Foss | Sep 2005 | B2 |
6953139 | Milliman et al. | Oct 2005 | B2 |
6959851 | Heinrich | Nov 2005 | B2 |
7009034 | Pathak et al. | Mar 2006 | B2 |
7025772 | Gellman et al. | Apr 2006 | B2 |
7032798 | Whitman et al. | Apr 2006 | B2 |
7060087 | DiMatteo et al. | Jun 2006 | B2 |
7066934 | Kirsch | Jun 2006 | B2 |
7087065 | Ulmsten et al. | Aug 2006 | B2 |
7108701 | Evens et al. | Sep 2006 | B2 |
7128253 | Mastri et al. | Oct 2006 | B2 |
7128748 | Mooradian et al. | Oct 2006 | B2 |
7129300 | Roby | Oct 2006 | B2 |
7134438 | Makower et al. | Nov 2006 | B2 |
7141055 | Abrams et al. | Nov 2006 | B2 |
7147138 | Shelton, IV | Dec 2006 | B2 |
7160299 | Baily | Jan 2007 | B2 |
7179268 | Roy et al. | Feb 2007 | B2 |
7210810 | Iversen et al. | May 2007 | B1 |
7214727 | Kwon et al. | May 2007 | B2 |
7217254 | Kirwan et al. | May 2007 | B2 |
7232449 | Sharkawy et al. | Jun 2007 | B2 |
7238195 | Viola | Jul 2007 | B2 |
7241300 | Sharkawy et al. | Jul 2007 | B2 |
7247338 | Pui et al. | Jul 2007 | B2 |
7279322 | Pui et al. | Oct 2007 | B2 |
7307031 | Carroll et al. | Dec 2007 | B2 |
7308998 | Mastri et al. | Dec 2007 | B2 |
7311720 | Mueller et al. | Dec 2007 | B2 |
7328829 | Arad et al. | Feb 2008 | B2 |
7334717 | Rethy et al. | Feb 2008 | B2 |
7347850 | Sawhney | Mar 2008 | B2 |
7377928 | Zubik et al. | May 2008 | B2 |
7419081 | Ehrenfels et al. | Sep 2008 | B2 |
7434717 | Shelton, IV et al. | Oct 2008 | B2 |
7438209 | Hess et al. | Oct 2008 | B1 |
7455682 | Viola | Nov 2008 | B2 |
7464849 | Shelton, IV et al. | Dec 2008 | B2 |
7498063 | Pui et al. | Mar 2009 | B2 |
7547312 | Bauman et al. | Jun 2009 | B2 |
7553923 | Williams et al. | Jun 2009 | B2 |
7559937 | de la Torre et al. | Jul 2009 | B2 |
7571845 | Viola | Aug 2009 | B2 |
7588565 | Marchitto et al. | Sep 2009 | B2 |
7592418 | Pathak et al. | Sep 2009 | B2 |
7594921 | Browning | Sep 2009 | B2 |
7595392 | Kumar et al. | Sep 2009 | B2 |
7604151 | Hess et al. | Oct 2009 | B2 |
7611494 | Campbell et al. | Nov 2009 | B2 |
7635073 | Heinrich | Dec 2009 | B2 |
7645874 | Saferstein et al. | Jan 2010 | B2 |
7649089 | Kumar et al. | Jan 2010 | B2 |
7655288 | Bauman et al. | Feb 2010 | B2 |
7662409 | Masters | Feb 2010 | B2 |
7662801 | Kumar et al. | Feb 2010 | B2 |
7665646 | Prommersberger | Feb 2010 | B2 |
7666198 | Suyker et al. | Feb 2010 | B2 |
7669747 | Weisenburgh, II et al. | Mar 2010 | B2 |
7673782 | Hess et al. | Mar 2010 | B2 |
7699204 | Viola | Apr 2010 | B2 |
7708180 | Murray et al. | May 2010 | B2 |
7709631 | Harris et al. | May 2010 | B2 |
7717313 | Criscuolo et al. | May 2010 | B2 |
7722642 | Williamson, IV et al. | May 2010 | B2 |
7735703 | Morgan et al. | Jun 2010 | B2 |
7740160 | Viola | Jun 2010 | B2 |
7744627 | Orban, III | Jun 2010 | B2 |
7754002 | Maase et al. | Jul 2010 | B2 |
7776060 | Mooradian et al. | Aug 2010 | B2 |
7789889 | Zubik et al. | Sep 2010 | B2 |
7793813 | Bettuchi | Sep 2010 | B2 |
7799026 | Schechter et al. | Sep 2010 | B2 |
7819896 | Racenet | Oct 2010 | B2 |
7823592 | Bettuchi et al. | Nov 2010 | B2 |
7824420 | Eldridge et al. | Nov 2010 | B2 |
7845533 | Marczyk et al. | Dec 2010 | B2 |
7845536 | Viola et al. | Dec 2010 | B2 |
7846149 | Jankowski | Dec 2010 | B2 |
7886951 | Hessler | Feb 2011 | B2 |
7892247 | Conston et al. | Feb 2011 | B2 |
7909224 | Prommersberger | Mar 2011 | B2 |
7909837 | Crews et al. | Mar 2011 | B2 |
7922743 | Heinrich et al. | Apr 2011 | B2 |
7938307 | Bettuchi | May 2011 | B2 |
7942890 | D'Agostino et al. | May 2011 | B2 |
7950561 | Aranyi | May 2011 | B2 |
7951166 | Orban, III et al. | May 2011 | B2 |
7951248 | Fallis et al. | May 2011 | B1 |
7967179 | Olson et al. | Jun 2011 | B2 |
7988027 | Olson et al. | Aug 2011 | B2 |
8011550 | Aranyi et al. | Sep 2011 | B2 |
8011555 | Tarinelli et al. | Sep 2011 | B2 |
8016177 | Bettuchi et al. | Sep 2011 | B2 |
8016178 | Olson et al. | Sep 2011 | B2 |
8025199 | Whitman et al. | Sep 2011 | B2 |
8028883 | Stopek | Oct 2011 | B2 |
8033483 | Fortier et al. | Oct 2011 | B2 |
8033983 | Chu et al. | Oct 2011 | B2 |
8038045 | Bettuchi et al. | Oct 2011 | B2 |
8062330 | Prommersberger et al. | Nov 2011 | B2 |
8062673 | Figuly et al. | Nov 2011 | B2 |
8066169 | Viola | Nov 2011 | B2 |
8083119 | Prommersberger | Dec 2011 | B2 |
8091756 | Viola | Jan 2012 | B2 |
8096458 | Hessler | Jan 2012 | B2 |
8123766 | Bauman et al. | Feb 2012 | B2 |
8123767 | Bauman et al. | Feb 2012 | B2 |
8127975 | Olson et al. | Mar 2012 | B2 |
8133336 | Kettlewell et al. | Mar 2012 | B2 |
8133559 | Lee et al. | Mar 2012 | B2 |
8146791 | Bettuchi et al. | Apr 2012 | B2 |
8152777 | Campbell et al. | Apr 2012 | B2 |
8157149 | Olson et al. | Apr 2012 | B2 |
8157151 | Ingmanson et al. | Apr 2012 | B2 |
8167895 | D'Agostino et al. | May 2012 | B2 |
8177797 | Shimoji et al. | May 2012 | B2 |
8178746 | Hildeberg et al. | May 2012 | B2 |
8192460 | Orban, III et al. | Jun 2012 | B2 |
8201720 | Hessler | Jun 2012 | B2 |
8210414 | Bettuchi et al. | Jul 2012 | B2 |
8210453 | Hull et al. | Jul 2012 | B2 |
8215314 | Chan et al. | Jul 2012 | B2 |
8225799 | Bettuchi | Jul 2012 | B2 |
8225981 | Criscuolo et al. | Jul 2012 | B2 |
8231043 | Tarinelli et al. | Jul 2012 | B2 |
8235273 | Olson et al. | Aug 2012 | B2 |
8245901 | Stopek | Aug 2012 | B2 |
8252339 | Figuly et al. | Aug 2012 | B2 |
8252921 | Vignon et al. | Aug 2012 | B2 |
8256654 | Bettuchi et al. | Sep 2012 | B2 |
8257391 | Orban, III et al. | Sep 2012 | B2 |
8276800 | Bettuchi | Oct 2012 | B2 |
8276802 | Kostrzewski | Oct 2012 | B2 |
8281975 | Criscuolo et al. | Oct 2012 | B2 |
8286849 | Bettuchi | Oct 2012 | B2 |
8286850 | Viola | Oct 2012 | B2 |
8308042 | Aranyi | Nov 2012 | B2 |
8308045 | Bettuchi et al. | Nov 2012 | B2 |
8308046 | Prommersberger | Nov 2012 | B2 |
8312885 | Bettuchi et al. | Nov 2012 | B2 |
8313014 | Bettuchi | Nov 2012 | B2 |
8317790 | Bell et al. | Nov 2012 | B2 |
8322588 | Viola | Dec 2012 | B2 |
8322590 | Patel et al. | Dec 2012 | B2 |
8348126 | Olson et al. | Jan 2013 | B2 |
8348130 | Shah et al. | Jan 2013 | B2 |
8353930 | Heinrich et al. | Jan 2013 | B2 |
8365972 | Aranyi et al. | Feb 2013 | B2 |
8367089 | Wan et al. | Feb 2013 | B2 |
8371491 | Huitema et al. | Feb 2013 | B2 |
8371492 | Aranyi et al. | Feb 2013 | B2 |
8371493 | Aranyi et al. | Feb 2013 | B2 |
8372094 | Bettuchi et al. | Feb 2013 | B2 |
8393514 | Shelton, IV et al. | Mar 2013 | B2 |
8393517 | Milo | Mar 2013 | B2 |
8408440 | Olson et al. | Apr 2013 | B2 |
8408480 | Hull et al. | Apr 2013 | B2 |
8413869 | Heinrich | Apr 2013 | B2 |
8413871 | Racenet et al. | Apr 2013 | B2 |
8418909 | Kostrzewski | Apr 2013 | B2 |
8424742 | Bettuchi | Apr 2013 | B2 |
8430291 | Heinrich et al. | Apr 2013 | B2 |
8453652 | Stopek | Jun 2013 | B2 |
8453904 | Eskaros et al. | Jun 2013 | B2 |
8453909 | Olson et al. | Jun 2013 | B2 |
8453910 | Bettuchi et al. | Jun 2013 | B2 |
8464925 | Hull et al. | Jun 2013 | B2 |
8470360 | McKay | Jun 2013 | B2 |
8474677 | Woodard, Jr. et al. | Jul 2013 | B2 |
8479968 | Hodgkinson et al. | Jul 2013 | B2 |
8485414 | Criscuolo et al. | Jul 2013 | B2 |
8490853 | Criscuolo et al. | Jul 2013 | B2 |
8496683 | Prommersberger et al. | Jul 2013 | B2 |
8511533 | Viola et al. | Aug 2013 | B2 |
8512402 | Marczyk et al. | Aug 2013 | B2 |
8518440 | Blaskovich et al. | Aug 2013 | B2 |
8529600 | Woodard, Jr. et al. | Sep 2013 | B2 |
8540128 | Shelton, IV et al. | Sep 2013 | B2 |
8540131 | Swayze | Sep 2013 | B2 |
8551138 | Orban, III et al. | Oct 2013 | B2 |
8556918 | Bauman et al. | Oct 2013 | B2 |
8561873 | Ingmanson et al. | Oct 2013 | B2 |
8579990 | Priewe | Nov 2013 | B2 |
8584920 | Hodgkinson | Nov 2013 | B2 |
8590762 | Hess et al. | Nov 2013 | B2 |
8616429 | Viola | Dec 2013 | B2 |
8616430 | (Prommersberger) Stopek et al. | Dec 2013 | B2 |
8617132 | Golzarian et al. | Dec 2013 | B2 |
8631989 | Aranyi et al. | Jan 2014 | B2 |
8646674 | Schulte et al. | Feb 2014 | B2 |
8668129 | Olson | Mar 2014 | B2 |
8678263 | Viola | Mar 2014 | B2 |
8679137 | Bauman et al. | Mar 2014 | B2 |
8684250 | Bettuchi | Apr 2014 | B2 |
8701958 | Shelton, IV et al. | Apr 2014 | B2 |
8721703 | Fowler | May 2014 | B2 |
8727197 | Hess et al. | May 2014 | B2 |
8740844 | Freyman et al. | Jun 2014 | B2 |
8757466 | Olson et al. | Jun 2014 | B2 |
8789737 | Hodgkinson et al. | Jul 2014 | B2 |
8814888 | Sgro | Aug 2014 | B2 |
8820606 | Hodgkinson | Sep 2014 | B2 |
8821523 | Heinrich et al. | Sep 2014 | B2 |
8827133 | Shelton, IV et al. | Sep 2014 | B2 |
8857694 | Shelton, IV et al. | Oct 2014 | B2 |
8864009 | Shelton, IV et al. | Oct 2014 | B2 |
8870050 | Hodgkinson | Oct 2014 | B2 |
8875970 | Viola | Nov 2014 | B2 |
8920443 | Hiles et al. | Dec 2014 | B2 |
8920444 | Hiles et al. | Dec 2014 | B2 |
8939344 | Olson et al. | Jan 2015 | B2 |
8956390 | Shah et al. | Feb 2015 | B2 |
8967448 | Carter et al. | Mar 2015 | B2 |
9005243 | Stopek et al. | Apr 2015 | B2 |
9010606 | Aranyi et al. | Apr 2015 | B2 |
9010608 | Casasanta, Jr. et al. | Apr 2015 | B2 |
9010609 | Carter et al. | Apr 2015 | B2 |
9010610 | Hodgkinson | Apr 2015 | B2 |
9010612 | Stevenson et al. | Apr 2015 | B2 |
9016543 | (Prommersberger) Stopek et al. | Apr 2015 | B2 |
9016544 | Hodgkinson et al. | Apr 2015 | B2 |
9027817 | Milliman et al. | May 2015 | B2 |
9044227 | Shelton, IV et al. | Jun 2015 | B2 |
9055944 | Hodgkinson et al. | Jun 2015 | B2 |
9084602 | Gleiman | Jul 2015 | B2 |
9107665 | Hodgkinson et al. | Aug 2015 | B2 |
9107667 | Hodgkinson | Aug 2015 | B2 |
9113871 | Milliman et al. | Aug 2015 | B2 |
9113872 | Viola | Aug 2015 | B2 |
9113873 | Marczyk et al. | Aug 2015 | B2 |
9113885 | Hodgkinson et al. | Aug 2015 | B2 |
9113893 | Sorrentino et al. | Aug 2015 | B2 |
9161753 | Prior | Oct 2015 | B2 |
9161757 | Bettuchi | Oct 2015 | B2 |
9186140 | Hiles et al. | Nov 2015 | B2 |
9186144 | Stevenson et al. | Nov 2015 | B2 |
9192378 | Aranyi et al. | Nov 2015 | B2 |
9192379 | Aranyi et al. | Nov 2015 | B2 |
9192380 | (Tarinelli) Racenet et al. | Nov 2015 | B2 |
9192383 | Milliman | Nov 2015 | B2 |
9192384 | Bettuchi | Nov 2015 | B2 |
9198660 | Hodgkinson | Dec 2015 | B2 |
9198663 | Marczyk et al. | Dec 2015 | B1 |
9204881 | Penna | Dec 2015 | B2 |
9220504 | Viola et al. | Dec 2015 | B2 |
9226754 | D'Agostino et al. | Jan 2016 | B2 |
9237892 | Hodgkinson | Jan 2016 | B2 |
9237893 | Carter et al. | Jan 2016 | B2 |
9277922 | Carter et al. | Mar 2016 | B2 |
9295466 | Hodgkinson et al. | Mar 2016 | B2 |
9326768 | Shelton, IV | May 2016 | B2 |
9326773 | Casasanta, Jr. et al. | May 2016 | B2 |
9328111 | Zhou et al. | May 2016 | B2 |
9345479 | (Tarinelli) Racenet et al. | May 2016 | B2 |
9351729 | Orban, III et al. | May 2016 | B2 |
9351731 | Carter et al. | May 2016 | B2 |
9351732 | Hodgkinson | May 2016 | B2 |
9358005 | Shelton, IV et al. | Jun 2016 | B2 |
9364229 | D'Agostino et al. | Jun 2016 | B2 |
9364234 | (Prommersberger) Stopek et al. | Jun 2016 | B2 |
9386988 | Baxter, III et al. | Jul 2016 | B2 |
9402627 | Stevenson et al. | Aug 2016 | B2 |
9414839 | Penna | Aug 2016 | B2 |
9433412 | Bettuchi et al. | Sep 2016 | B2 |
9433413 | Stopek | Sep 2016 | B2 |
9433420 | Hodgkinson | Sep 2016 | B2 |
9445812 | Olson et al. | Sep 2016 | B2 |
9445817 | Bettuchi | Sep 2016 | B2 |
9456821 | Bettuchi et al. | Oct 2016 | B2 |
9463260 | Stopek | Oct 2016 | B2 |
9486215 | Olson et al. | Nov 2016 | B2 |
9492170 | Bear et al. | Nov 2016 | B2 |
9504470 | Milliman | Nov 2016 | B2 |
9517164 | Vitaris et al. | Dec 2016 | B2 |
9572576 | Hodgkinson et al. | Feb 2017 | B2 |
9585657 | Shelton, IV et al. | Mar 2017 | B2 |
9597077 | Hodgkinson | Mar 2017 | B2 |
9610080 | Whitfield et al. | Apr 2017 | B2 |
9622745 | Ingmanson et al. | Apr 2017 | B2 |
9629626 | Soltz et al. | Apr 2017 | B2 |
9636850 | Stopek (Prommersberger) et al. | May 2017 | B2 |
9655620 | Prescott et al. | May 2017 | B2 |
9675351 | Hodgkinson et al. | Jun 2017 | B2 |
9681936 | Hodgkinson et al. | Jun 2017 | B2 |
9687262 | Rousseau et al. | Jun 2017 | B2 |
9693772 | Ingmanson et al. | Jul 2017 | B2 |
9708184 | Chan et al. | Jul 2017 | B2 |
9770245 | Swayze et al. | Sep 2017 | B2 |
9775617 | Carter et al. | Oct 2017 | B2 |
9775618 | Bettuchi et al. | Oct 2017 | B2 |
9782173 | Mozdzierz | Oct 2017 | B2 |
9844378 | Casasanta et al. | Dec 2017 | B2 |
9918713 | Zergiebel et al. | Mar 2018 | B2 |
9931116 | Racenet et al. | Apr 2018 | B2 |
10022125 | (Prommersberger) Stopek et al. | Jul 2018 | B2 |
10076333 | Bettuchi et al. | Sep 2018 | B2 |
10130368 | Matonick | Nov 2018 | B2 |
10595873 | Franklin, Sr. | Mar 2020 | B2 |
10743866 | Scheib | Aug 2020 | B2 |
20010007069 | Bombard et al. | Jul 2001 | A1 |
20020010482 | Watt | Jan 2002 | A1 |
20020013591 | Fleischman et al. | Jan 2002 | A1 |
20020026159 | Zhu et al. | Feb 2002 | A1 |
20020028243 | Masters | Mar 2002 | A1 |
20020049454 | Whitman et al. | Apr 2002 | A1 |
20020091397 | Chen | Jul 2002 | A1 |
20020151911 | Gabbay | Oct 2002 | A1 |
20020156150 | Williams et al. | Oct 2002 | A1 |
20020165559 | Grant | Nov 2002 | A1 |
20020165562 | Grant et al. | Nov 2002 | A1 |
20020173558 | Williams et al. | Nov 2002 | A1 |
20030014064 | Blatter | Jan 2003 | A1 |
20030032734 | Roby | Feb 2003 | A1 |
20030050590 | Kirsch | Mar 2003 | A1 |
20030065345 | Weadock | Apr 2003 | A1 |
20030073981 | Whitman et al. | Apr 2003 | A1 |
20030073982 | Whitman | Apr 2003 | A1 |
20030078209 | Schmidt | Apr 2003 | A1 |
20030083676 | Wallace | May 2003 | A1 |
20030089757 | Whitman | May 2003 | A1 |
20030111507 | Nunez | Jun 2003 | A1 |
20030120284 | Palacios et al. | Jun 2003 | A1 |
20030125676 | Swenson et al. | Jul 2003 | A1 |
20030167064 | Whayne | Sep 2003 | A1 |
20030181927 | Wallace | Sep 2003 | A1 |
20030183671 | Mooradian | Oct 2003 | A1 |
20030208231 | Williamson et al. | Nov 2003 | A1 |
20030236518 | Marchitto et al. | Dec 2003 | A1 |
20040002726 | Nunez | Jan 2004 | A1 |
20040059283 | Kirwan et al. | Mar 2004 | A1 |
20040068078 | Milbocker | Apr 2004 | A1 |
20040092912 | Jinno et al. | May 2004 | A1 |
20040092960 | Abrams et al. | May 2004 | A1 |
20040093029 | Zubik et al. | May 2004 | A1 |
20040107006 | Francis et al. | Jun 2004 | A1 |
20040115229 | Roby | Jun 2004 | A1 |
20040131418 | Budde et al. | Jul 2004 | A1 |
20040236419 | Milo | Nov 2004 | A1 |
20040254590 | Hoffman et al. | Dec 2004 | A1 |
20040260315 | Dell et al. | Dec 2004 | A1 |
20050002981 | Lahtinen et al. | Jan 2005 | A1 |
20050006429 | Wales et al. | Jan 2005 | A1 |
20050021085 | Abrams et al. | Jan 2005 | A1 |
20050033331 | Burnett et al. | Feb 2005 | A1 |
20050038471 | Chan et al. | Feb 2005 | A1 |
20050043678 | Freyman et al. | Feb 2005 | A1 |
20050055039 | Burnett et al. | Mar 2005 | A1 |
20050059996 | Bauman et al. | Mar 2005 | A1 |
20050059997 | Bauman et al. | Mar 2005 | A1 |
20050070929 | Dalessandro et al. | Mar 2005 | A1 |
20050096673 | Stack et al. | May 2005 | A1 |
20050118435 | DeLucia et al. | Jun 2005 | A1 |
20050143756 | Jankowski | Jun 2005 | A1 |
20050149073 | Arani et al. | Jul 2005 | A1 |
20050228446 | Mooradian et al. | Oct 2005 | A1 |
20050230453 | Viola | Oct 2005 | A1 |
20050267325 | Bouchier | Dec 2005 | A1 |
20050283256 | Sommerich et al. | Dec 2005 | A1 |
20060004407 | Hiles et al. | Jan 2006 | A1 |
20060008505 | Brandon | Jan 2006 | A1 |
20060085032 | Viola | Apr 2006 | A1 |
20060085033 | Criscuolo et al. | Apr 2006 | A1 |
20060108393 | Heinrich et al. | May 2006 | A1 |
20060121266 | Fandel et al. | Jun 2006 | A1 |
20060135992 | Bettuchi et al. | Jun 2006 | A1 |
20060173470 | Oray et al. | Aug 2006 | A1 |
20060178683 | Shimoji et al. | Aug 2006 | A1 |
20060190027 | Downey | Aug 2006 | A1 |
20060271104 | Viola et al. | Nov 2006 | A1 |
20070026031 | Bauman et al. | Feb 2007 | A1 |
20070034669 | de la Torre et al. | Feb 2007 | A1 |
20070049953 | Shimoji et al. | Mar 2007 | A2 |
20070123839 | Rousseau et al. | May 2007 | A1 |
20070179528 | Soltz et al. | Aug 2007 | A1 |
20070203509 | Bettuchi | Aug 2007 | A1 |
20070203510 | Bettuchi | Aug 2007 | A1 |
20070243227 | Gertner | Oct 2007 | A1 |
20070246505 | Pace-Floridia et al. | Oct 2007 | A1 |
20080009811 | Cantor | Jan 2008 | A1 |
20080029570 | Shelton et al. | Feb 2008 | A1 |
20080082126 | Murray et al. | Apr 2008 | A1 |
20080110959 | Orban et al. | May 2008 | A1 |
20080125812 | Zubik et al. | May 2008 | A1 |
20080140115 | Stopek | Jun 2008 | A1 |
20080161831 | Bauman et al. | Jul 2008 | A1 |
20080161832 | Bauman et al. | Jul 2008 | A1 |
20080169327 | Shelton et al. | Jul 2008 | A1 |
20080169328 | Shelton | Jul 2008 | A1 |
20080169329 | Shelton et al. | Jul 2008 | A1 |
20080169330 | Shelton et al. | Jul 2008 | A1 |
20080169331 | Shelton et al. | Jul 2008 | A1 |
20080169332 | Shelton et al. | Jul 2008 | A1 |
20080169333 | Shelton et al. | Jul 2008 | A1 |
20080200949 | Hiles et al. | Aug 2008 | A1 |
20080216855 | Nasca | Sep 2008 | A1 |
20080220047 | Sawhney et al. | Sep 2008 | A1 |
20080230583 | Heinrich | Sep 2008 | A1 |
20080290134 | Bettuchi et al. | Nov 2008 | A1 |
20080308608 | Prommersberger | Dec 2008 | A1 |
20080314960 | Marczyk et al. | Dec 2008 | A1 |
20090001121 | Hess et al. | Jan 2009 | A1 |
20090001122 | Prommersberger et al. | Jan 2009 | A1 |
20090001123 | Morgan et al. | Jan 2009 | A1 |
20090001124 | Hess et al. | Jan 2009 | A1 |
20090001125 | Hess et al. | Jan 2009 | A1 |
20090001126 | Hess et al. | Jan 2009 | A1 |
20090001128 | Weisenburgh, II et al. | Jan 2009 | A1 |
20090001130 | Hess et al. | Jan 2009 | A1 |
20090005808 | Hess et al. | Jan 2009 | A1 |
20090030452 | Bauman et al. | Jan 2009 | A1 |
20090031842 | Kawai et al. | Feb 2009 | A1 |
20090043334 | Bauman et al. | Feb 2009 | A1 |
20090076510 | Bell et al. | Mar 2009 | A1 |
20090076528 | Sgro | Mar 2009 | A1 |
20090078739 | Viola | Mar 2009 | A1 |
20090095791 | Eskaros et al. | Apr 2009 | A1 |
20090095792 | Bettuchi | Apr 2009 | A1 |
20090120994 | Murray et al. | May 2009 | A1 |
20090134200 | Tarinelli et al. | May 2009 | A1 |
20090206125 | Huitema et al. | Aug 2009 | A1 |
20090206126 | Huitema et al. | Aug 2009 | A1 |
20090206139 | Hall et al. | Aug 2009 | A1 |
20090206141 | Huitema et al. | Aug 2009 | A1 |
20090206142 | Huitema et al. | Aug 2009 | A1 |
20090206143 | Huitema et al. | Aug 2009 | A1 |
20090218384 | Aranyi | Sep 2009 | A1 |
20090277944 | Dalessandro et al. | Nov 2009 | A9 |
20090277947 | Viola | Nov 2009 | A1 |
20090287230 | D'Agostino et al. | Nov 2009 | A1 |
20100012704 | Tarinelli Racenet et al. | Jan 2010 | A1 |
20100016855 | Ramstein et al. | Jan 2010 | A1 |
20100016888 | Calabrese et al. | Jan 2010 | A1 |
20100065606 | Stopek | Mar 2010 | A1 |
20100065607 | Orban, III et al. | Mar 2010 | A1 |
20100072254 | Aranyi et al. | Mar 2010 | A1 |
20100087840 | Ebersole et al. | Apr 2010 | A1 |
20100147921 | Olson | Jun 2010 | A1 |
20100147922 | Olson | Jun 2010 | A1 |
20100147923 | D'Agostino et al. | Jun 2010 | A1 |
20100174253 | Cline et al. | Jul 2010 | A1 |
20100203151 | Hiraoka | Aug 2010 | A1 |
20100230466 | Criscuolo et al. | Sep 2010 | A1 |
20100243707 | Olson et al. | Sep 2010 | A1 |
20100243708 | Aranyi et al. | Sep 2010 | A1 |
20100243711 | Olson et al. | Sep 2010 | A1 |
20100249805 | Olson et al. | Sep 2010 | A1 |
20100264195 | Bettuchi | Oct 2010 | A1 |
20100282815 | Bettuchi et al. | Nov 2010 | A1 |
20100331859 | Omori | Dec 2010 | A1 |
20100331880 | Stopek | Dec 2010 | A1 |
20110024476 | Bettuchi et al. | Feb 2011 | A1 |
20110024481 | Bettuchi et al. | Feb 2011 | A1 |
20110034910 | Ross et al. | Feb 2011 | A1 |
20110036889 | Heinrich et al. | Feb 2011 | A1 |
20110036894 | Bettuchi | Feb 2011 | A1 |
20110042442 | Viola et al. | Feb 2011 | A1 |
20110046650 | Bettuchi | Feb 2011 | A1 |
20110057016 | Bettuchi | Mar 2011 | A1 |
20110087279 | Shah et al. | Apr 2011 | A1 |
20110089220 | Ingmanson et al. | Apr 2011 | A1 |
20110125138 | Malinouskas et al. | May 2011 | A1 |
20110166673 | Patel et al. | Jul 2011 | A1 |
20110215132 | Aranyi et al. | Sep 2011 | A1 |
20110278346 | Hull | Nov 2011 | A1 |
20110293690 | Griffin et al. | Dec 2011 | A1 |
20120074199 | Olson et al. | Mar 2012 | A1 |
20120080336 | Shelton, IV et al. | Apr 2012 | A1 |
20120083723 | Vitaris et al. | Apr 2012 | A1 |
20120187179 | Gleiman | Jul 2012 | A1 |
20120197272 | Oray et al. | Aug 2012 | A1 |
20120241491 | Aldridge et al. | Sep 2012 | A1 |
20120241493 | Baxter, III et al. | Sep 2012 | A1 |
20120241499 | Baxter, III et al. | Sep 2012 | A1 |
20120253298 | Henderson et al. | Oct 2012 | A1 |
20120273547 | Hodgkinson et al. | Nov 2012 | A1 |
20130008937 | Viola | Jan 2013 | A1 |
20130037596 | Bear et al. | Feb 2013 | A1 |
20130105548 | Hodgkinson et al. | May 2013 | A1 |
20130105553 | (Tarinelli) Racenet et al. | May 2013 | A1 |
20130112732 | Aranyi et al. | May 2013 | A1 |
20130112733 | Aranyi et al. | May 2013 | A1 |
20130146641 | Shelton, IV et al. | Jun 2013 | A1 |
20130153633 | Casasanta, Jr. et al. | Jun 2013 | A1 |
20130153634 | Carter et al. | Jun 2013 | A1 |
20130153635 | Hodgkinson | Jun 2013 | A1 |
20130153636 | Shelton, IV et al. | Jun 2013 | A1 |
20130153638 | Carter et al. | Jun 2013 | A1 |
20130153639 | Hodgkinson et al. | Jun 2013 | A1 |
20130153640 | Hodgkinson | Jun 2013 | A1 |
20130153641 | Shelton, IV et al. | Jun 2013 | A1 |
20130161374 | Swayze et al. | Jun 2013 | A1 |
20130181031 | Olson et al. | Jul 2013 | A1 |
20130193186 | (Tarinelli) Racenet et al. | Aug 2013 | A1 |
20130193190 | Carter et al. | Aug 2013 | A1 |
20130193191 | Stevenson et al. | Aug 2013 | A1 |
20130193192 | Casasanta, Jr. et al. | Aug 2013 | A1 |
20130209659 | Racenet et al. | Aug 2013 | A1 |
20130221062 | Hodgkinson | Aug 2013 | A1 |
20130240600 | Bettuchi | Sep 2013 | A1 |
20130240601 | Bettuchi et al. | Sep 2013 | A1 |
20130240602 | Stopek | Sep 2013 | A1 |
20130256380 | Schmid et al. | Oct 2013 | A1 |
20130277411 | Hodgkinson et al. | Oct 2013 | A1 |
20130292449 | Bettuchi et al. | Nov 2013 | A1 |
20130306707 | Viola et al. | Nov 2013 | A1 |
20130310873 | Stopek (Prommersberger) et al. | Nov 2013 | A1 |
20130327807 | Olson et al. | Dec 2013 | A1 |
20140012317 | Orban et al. | Jan 2014 | A1 |
20140021242 | Hodgkinson et al. | Jan 2014 | A1 |
20140027490 | Marczyk et al. | Jan 2014 | A1 |
20140034704 | Ingmanson et al. | Feb 2014 | A1 |
20140048580 | Merchant et al. | Feb 2014 | A1 |
20140061280 | Ingmanson et al. | Mar 2014 | A1 |
20140061281 | Hodgkinson | Mar 2014 | A1 |
20140084042 | (Prommersberger) Stopek et al. | Mar 2014 | A1 |
20140097224 | Prior | Apr 2014 | A1 |
20140117066 | Aranyi et al. | May 2014 | A1 |
20140130330 | Olson et al. | May 2014 | A1 |
20140131418 | Kostrzewski | May 2014 | A1 |
20140131419 | Bettuchi | May 2014 | A1 |
20140138423 | Whitfield et al. | May 2014 | A1 |
20140151431 | Hodgkinson et al. | Jun 2014 | A1 |
20140155916 | Hodgkinson et al. | Jun 2014 | A1 |
20140158742 | Stopek (Prommersberger) et al. | Jun 2014 | A1 |
20140166721 | Stevenson et al. | Jun 2014 | A1 |
20140197224 | Penna | Jul 2014 | A1 |
20140203061 | Hodgkinson | Jul 2014 | A1 |
20140217147 | Milliman | Aug 2014 | A1 |
20140217148 | Penna | Aug 2014 | A1 |
20140231488 | Holsten | Aug 2014 | A1 |
20140239046 | Milliman | Aug 2014 | A1 |
20140239047 | Hodgkinson et al. | Aug 2014 | A1 |
20140252062 | Mozdzierz | Sep 2014 | A1 |
20150001276 | Hodgkinson et al. | Jan 2015 | A1 |
20150041347 | Hodgkinson | Feb 2015 | A1 |
20150097018 | Hodgkinson | Apr 2015 | A1 |
20150115015 | Prescott et al. | Apr 2015 | A1 |
20150133995 | Shelton, IV et al. | May 2015 | A1 |
20150157321 | Zergiebel et al. | Jun 2015 | A1 |
20150209045 | Hodgkinson et al. | Jul 2015 | A1 |
20150231409 | Racenet et al. | Aug 2015 | A1 |
20150327864 | Hodgkinson et al. | Nov 2015 | A1 |
20150351753 | Shelton, IV et al. | Dec 2015 | A1 |
20150351758 | Shelton, IV et al. | Dec 2015 | A1 |
20160022268 | Prior | Jan 2016 | A1 |
20160045200 | Milliman | Feb 2016 | A1 |
20160095592 | Levinson et al. | Apr 2016 | A1 |
20160100834 | Viola et al. | Apr 2016 | A1 |
20160106430 | Carter et al. | Apr 2016 | A1 |
20160157857 | Hodgkinson et al. | Jun 2016 | A1 |
20160174988 | D'Agostino et al. | Jun 2016 | A1 |
20160206315 | Olson | Jul 2016 | A1 |
20160220257 | Casasanta et al. | Aug 2016 | A1 |
20160249923 | Hodgkinson et al. | Sep 2016 | A1 |
20160270793 | Carter et al. | Sep 2016 | A1 |
20160310143 | Bettuchi | Oct 2016 | A1 |
20160338704 | Penna | Nov 2016 | A1 |
20160367252 | Olson et al. | Dec 2016 | A1 |
20160367253 | Hodgkinson | Dec 2016 | A1 |
20160367257 | Stevenson et al. | Dec 2016 | A1 |
20170042540 | Olson et al. | Feb 2017 | A1 |
20170049452 | Milliman | Feb 2017 | A1 |
20170150967 | Hodgkinson et al. | Jun 2017 | A1 |
20170172575 | Hodgkinson | Jun 2017 | A1 |
20170231629 | Stopek et al. | Aug 2017 | A1 |
20170238931 | Prescott et al. | Aug 2017 | A1 |
20170281328 | Hodgkinson et al. | Oct 2017 | A1 |
20170296188 | Ingmanson et al. | Oct 2017 | A1 |
20170354415 | Casasanta, Jr. et al. | Dec 2017 | A1 |
20180085120 | Viola | Mar 2018 | A1 |
20180125491 | Aranyi | May 2018 | A1 |
20180140301 | Milliman | May 2018 | A1 |
20180168654 | Hodgkinson et al. | Jun 2018 | A1 |
20180214147 | Merchant et al. | Aug 2018 | A1 |
Number | Date | Country |
---|---|---|
2282761 | Sep 1998 | CA |
2 667 434 | May 2008 | CA |
101310680 | Nov 2008 | CN |
101332110 | Dec 2008 | CN |
1602563 | Mar 1950 | DE |
19924311 | Nov 2000 | DE |
0327022 | Aug 1989 | EP |
0577373 | Jan 1994 | EP |
0594148 | Apr 1994 | EP |
0667119 | Aug 1995 | EP |
1064883 | Jan 2001 | EP |
1256317 | Nov 2002 | EP |
1256318 | Nov 2002 | EP |
1520525 | Apr 2005 | EP |
1621141 | Feb 2006 | EP |
1702570 | Sep 2006 | EP |
1759640 | Mar 2007 | EP |
1815804 | Aug 2007 | EP |
1825820 | Aug 2007 | EP |
1929958 | Jun 2008 | EP |
1994890 | Nov 2008 | EP |
2005894 | Dec 2008 | EP |
2005895 | Dec 2008 | EP |
2008595 | Dec 2008 | EP |
2039308 | Mar 2009 | EP |
2090231 | Aug 2009 | EP |
2090244 | Aug 2009 | EP |
2090252 | Aug 2009 | EP |
2163211 | Mar 2010 | EP |
2189121 | May 2010 | EP |
2198787 | Jun 2010 | EP |
2236098 | Oct 2010 | EP |
2236099 | Oct 2010 | EP |
2258282 | Dec 2010 | EP |
2292276 | Mar 2011 | EP |
2311386 | Apr 2011 | EP |
2436348 | Apr 2012 | EP |
2462880 | Jun 2012 | EP |
2491867 | Aug 2012 | EP |
2497431 | Sep 2012 | EP |
2517637 | Oct 2012 | EP |
2586380 | May 2013 | EP |
2604195 | Jun 2013 | EP |
2604197 | Jun 2013 | EP |
2620105 | Jul 2013 | EP |
2620106 | Jul 2013 | EP |
2630922 | Aug 2013 | EP |
2644125 | Oct 2013 | EP |
2762091 | Aug 2014 | EP |
06327683 | Nov 1994 | JP |
2000166933 | Jun 2000 | JP |
2002202213 | Jul 2002 | JP |
2007124166 | May 2007 | JP |
2010214132 | Sep 2010 | JP |
9005489 | May 1990 | WO |
9516221 | Jun 1995 | WO |
9622055 | Jul 1996 | WO |
9801989 | Jan 1997 | WO |
9713463 | Apr 1997 | WO |
9817180 | Apr 1998 | WO |
9838923 | Sep 1998 | WO |
9926826 | Jun 1999 | WO |
9945849 | Sep 1999 | WO |
0010456 | Mar 2000 | WO |
0016684 | Mar 2000 | WO |
0056376 | Sep 2000 | WO |
0162158 | Aug 2001 | WO |
0162162 | Aug 2001 | WO |
2002030297 | Apr 2002 | WO |
0308844 | Oct 2003 | WO |
03082126 | Oct 2003 | WO |
03088845 | Oct 2003 | WO |
03094743 | Nov 2003 | WO |
03094746 | Nov 2003 | WO |
03105698 | Dec 2003 | WO |
2005079675 | Sep 2005 | WO |
2006023578 | Mar 2006 | WO |
2006044490 | Apr 2006 | WO |
2006083748 | Aug 2006 | WO |
2007121579 | Nov 2007 | WO |
2008057281 | May 2008 | WO |
2008109125 | Sep 2008 | WO |
2010075298 | Jul 2010 | WO |
2011143183 | Nov 2011 | WO |
2012044848 | Apr 2012 | WO |
Entry |
---|
International Search Report corresponding to European Application No. EP 05809831.0-1269, completed on May 4, 2012 and dated May 14, 2012; 10 pages. |
Extended European Search Report corresponding to EP 14 16 9739.1, completed Aug. 9, 2014 and dated Aug. 29, 2014; (7 pp). |
Extended European Search Report corresponding to EP 14 15 7997.9, completed Sep. 9, 2014 and dated Sep. 17, 2014; (8 pp). |
Extended European Search Report corresponding to EP 14 16 8904.2, completed Sep. 10, 2014 and dated Sep. 18, 2014; (8 pp). |
Extended European Search Report corresponding to EP 13 19 4995.0, completed Jun. 5, 2014 and dated Oct. 13, 2014; (10 pp). |
Extended European Search Report corresponding to EP 13 15 4571.7, completed Oct. 10, 2014 and dated Oct. 20, 2014; (8 pp). |
Extended European Search Report corresponding to EP 14 18 1125.7, completed Oct. 16, 2014 and dated Oct. 24, 2014; (7 pp). |
Extended European Search Report corresponding to EP 14 18 1127.3, completed Oct. 16, 2014 and dated Nov. 10, 2014; (8 pp). |
Extended European Search Report corresponding to EP 14 19 0419.3, completed Mar. 24, 2015 and dated Mar. 30, 2015; (6 pp). |
European Search Report corresponding to EP 05 02 2585.3, completed Jan. 25, 2006 and dated Feb. 3, 2006; 4 pages. |
European Search Report corresponding to EP 06 00 4598, completed Jun. 22, 2006; 2 pages. |
European Search Report corresponding to EP 06 01 6962.0, completed Jan. 3, 2007 and dated Jan. 11, 2007; 10 pages. |
International Search Report corresponding to International Application No. PCT/US2005/036740, completed Feb. 20, 2007 and dated Mar. 23, 2007; 8 pages. |
International Search Report corresponding to International Application No. PCT/US2007/022713, completed Apr. 21, 2008 and dated May 15, 2008; 1 page. |
International Search Report corresponding to International Application No. PCT/US2008/002981, completed Jun. 9, 2008 and dated Jun. 26, 2008; 2 pages. |
European Search Report corresponding to EP 08 25 1779, completed Jul. 14, 2008 and dated Jul. 23, 2008; 5 pages. |
European Search Report corresponding to EP 08 25 1989.3, completed Mar. 11, 2010 and dated Mar. 24, 2010; 6 pages. |
European Search Report corresponding to EP 10 25 0639.1, completed Jun. 17, 2010 and dated Jun. 28, 2010; 7 pages. |
European Search Report corresponding to EP 10 25 0715.9, completed Jun. 30, 2010 and dated Jul. 20, 2010; 3 pages. |
European Search Report corresponding to EP 05 80 4382.9, completed Oct. 5, 2010 and dated Oct. 12, 2010; 3 pages. |
European Search Report corresponding to EP 10 25 1437.9, completed Nov. 22, 2010 and dated Dec. 16, 2010; 3 pages. |
European Search Report corresponding to EP 09 25 2897.5, completed Feb. 7, 2011 and dated Feb. 15, 2011; 3 pages. |
European Search Report corresponding to EP 10 25 0642.5, completed Mar. 25, 2011 and dated Apr. 4, 2011; 4 pages. |
European Search Report corresponding to EP 11 18 8309.6, completed Dec. 15, 2011 and dated Jan. 12, 2012; 3 pages. |
European Search Report corresponding to EP 12 15 2229.6, completed Feb. 23, 2012 and dated Mar. 1, 2012; 4 pages. |
European Search Report corresponding to EP 12 15 0511.9, completed Apr. 16, 2012 and dated Apr. 24, 2012; 7 pages. |
European Search Report corresponding to EP 12 15 2541.4, completed Apr. 23, 2012 and dated May 3, 2012; 10 pages. |
European Search Report corresponding to EP 12 16 5609.4, completed Jul. 5, 2012 and dated Jul. 13, 2012; 8 pages. |
European Search Report corresponding to EP 12 15 8861.0, completed Jul. 17, 2012 and dated Jul. 24, 2012; 9 pages. |
European Search Report corresponding to EP 12 16 5878.5, completed Jul. 24, 2012 and dated Aug. 6, 2012; 8 pages. |
Extended European Search Report corresponding to EP 12 19 1035.0, completed Jan. 11, 2013 and dated Jan. 18, 2013; 7 pages. |
Extended European Search Report corresponding to EP 12 18 6175.1, completed Jan. 15, 2013 and dated Jan. 23, 2013; 7 pages. |
Extended European Search Report corresponding to EP 12 19 1114.3, completed Jan. 23, 2013 and dated Jan. 31, 2013; 10 pages. |
Extended European Search Report corresponding to EP 12 19 2224.9, completed Mar. 14, 2013 and dated Mar. 26, 2013; 8 pages. |
Extended European Search Report corresponding to EP 12 19 6911.7, completed Apr. 18, 2013 and dated Apr. 24, 2013; 8 pages. |
Extended European Search Report corresponding to EP 08 72 6500.5, completed Feb. 20, 2014 and dated Mar. 3, 2014; (7 pp). |
Extended European Search Report corresponding to EP 13 19 5919.9, completed Feb. 10, 2014 and dated Mar. 3, 2014; (7 pp). |
Extended European Search Report corresponding to EP 13 19 2123.1, completed Jan. 30, 2014 and dated Feb. 10, 2014; (8 pp). |
Extended European Search Report corresponding to EP 13 19 6816.6, completed Mar. 28, 2014 and dated Apr. 9, 2014; (9 pp). |
Extended European Search Report corresponding to EP 13 19 4995.0, completed Jun. 5, 2014 and dated Jun. 16, 2014; (5 pp). |
Extended European Search Report corresponding to EP 13 19 5019.8, completed Mar. 14, 2014 and dated Mar. 24, 2014; (7 pp). |
Extended European Search Report corresponding to EP 13 19 2111.6, completed Feb. 13, 2014 and dated Feb. 27, 2014; (10 pp). |
Extended European Search Report corresponding to EP 13 19 7958.5, completed Apr. 4, 2014 and dated Apr. 15, 2014; (8 pp). |
Extended European Search Report corresponding to EP 14 15 6342.9, completed Jul. 22, 2014 and dated Jul. 29, 2014; (8 pp). |
Extended European Search Report corresponding to EP 14 15 7195.0, completed Jun. 5, 2014 and dated Jun. 18, 2014; (9 pp). |
Extended European Search Report corresponding to EP 12 19 6904.2, completed Mar. 28, 2013 and dated Jul. 26, 2013; 8 pages. |
Extended European Search Report corresponding to EP 12 19 8749.9, completed May 21, 2013 and dated May 31, 2013; 8 pages. |
Extended European Search Report corresponding to EP 07 00 5842.5, completed May 13, 2013 and dated May 29, 2013; 7 pages. |
Extended European Search Report corresponding to EP 12 19 8776.2, completed May 16, 2013 and dated May 27, 2013; 8 pages. |
Extended European Search Report corresponding to EP 13 15 6297.7, completed Jun. 4, 2013 and dated Jun. 13, 2013; 7 pages. |
Extended European Search Report corresponding to EP 13 17 3985.6, completed Aug. 19, 2013 and dated Aug. 28, 2013; 6 pages. |
Extended European Search Report corresponding to EP 13 17 3986.4, completed Aug. 20, 2013 and dated Aug. 29, 2013; 7 pages. |
Extended European Search Report corresponding to EP 13 17 7437.4, completed Sep. 11, 2013 and dated Sep. 19, 2013; (6 pp). |
Extended European Search Report corresponding to EP 13 17 7441.6, completed Sep. 11, 2013 and dated Sep. 19, 2013; (6 pp). |
Extended European Search Report corresponding to EP 07 86 1534.1, completed Sep. 20, 2013 and dated Sep. 30, 2013; (5 pp). |
Extended European Search Report corresponding to EP 13 18 3876.5, completed Oct. 14, 2013 and dated Oct. 24, 2013; (5 pp). |
Extended European Search Report corresponding to EP 13 17 1856.1, completed Oct. 29, 2013 and dated Nov. 7, 2013; (8 pp). |
Extended European Search Report corresponding to EP 13 18 0373.6, completed Oct. 31, 2013 and dated Nov. 13, 2013; (7 pp). |
Extended European Search Report corresponding to EP 13 18 0881.8, completed Nov. 5, 2013 and dated Nov. 14, 2013; (6 pp). |
Extended European Search Report corresponding to EP 13 17 6895.4, completed Nov. 29, 2013 and dated Dec. 12, 2013; (5 pp). |
Extended European Search Report corresponding to EP 13 18 2911.1, completed Dec. 2, 2013 and dated Dec. 16, 2013; (8 pp). |
Extended European Search Report corresponding to EP 10 25 1795.0, completed Dec. 11, 2013 and dated Dec. 20, 2013; (6 pp). |
Extended European Search Report corresponding to EP 13 18 7911.6, completed Jan. 22, 2014 and dated Jan. 31, 2014; (8 pp). |
European Office Action corresponding to counterpart Int'l Appln No. EP 12 198 776.2 dated Apr. 7, 2015. |
European Office Action corresponding to counterpart Int'l Appln No. EP 13 156 297.7 dated Apr. 10, 2015. |
Australian Examination Report No. 1 corresponding to counterpart Int'l Appln No. AU 2011250822 dated May 18, 2015. |
European Office Action corresponding to counterpart Int'l Appln No. EP 12 186 175.1 dated Jun. 1, 2015. |
Chinese Office Action corresponding to counterpart Int'l Appln No. CN 201010517292.8 dated Jun. 2, 2015. |
Extended European Search Report corresponding to counterpart Int'l Appln No. EP 14 17 48145 dated Jun. 9, 2015. |
Australian Examination Report No. 1 corresponding to counterpart Int'l Appln No. AU 2014200584 dated Jun. 15, 2015. |
European Office Action corresponding to counterpart Int'l Appln No. EP 13 180 881.8 dated Jun. 19, 2015. |
European Office Action corresponding to counterpart Int'l Appln No. EP 14 157 195.0 dated Jul. 2, 2015. |
Extended European Search Report corresponding to counterpart Int'l Appln No. EP 12 19 6902.6 dated Aug. 6, 2015. |
Extended European Search Report corresponding to counterpart Int'l Appln No. EP 14 15 2060.1 dated Aug. 14, 2015. |
Chinese Office Action corresponding to counterpart Int'l Appln No. CN 201210129787.2 dated Aug. 24, 2015. |
International Search Report corresponding to European Application No. EP 05809831.0-1269, dated May 14, 2012. |
Number | Date | Country | |
---|---|---|---|
20190175180 A1 | Jun 2019 | US |
Number | Date | Country | |
---|---|---|---|
60620065 | Oct 2004 | US | |
60620066 | Oct 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13848265 | Mar 2013 | US |
Child | 15201875 | US | |
Parent | 11241267 | Sep 2005 | US |
Child | 13076550 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15201875 | Jul 2016 | US |
Child | 16278801 | US | |
Parent | 13076550 | Mar 2011 | US |
Child | 13848265 | US |